Rossari Biotech reported Q3 revenue up 13% to Rs. 581.7 Cr and PAT up 3% to Rs. 32.8 Cr.

The Board approved setting up greenfield specialty chemicals facilities in KSA, aiming to enhance supply chain resilience and accelerate speed-to-market.